Orexo AB
Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Its products include Zubsolv tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of short-term insomnia. The company's development products comprise OX124, a medication for naloxone rescue; OX125, a medication for nalmefene rescue; OX640, a medication for allergic reactions; and OX338 sublingual tablet formulation of ketorolac for treatment of moderate to severe pain. It is also developing OX-MPI program for the treatment of microvascular diseases in chronic inflammatory conditions. The company's digital therapies comprise deprexis therapy for the treatment of mild to severe depression; vorvida for alcohol use disorder; and modia for opioid use disorder. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden. Show More...
-
Website https://www.orexo.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 14.52 SEK
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share SEK -3.81 -14.43 -2.92 -5.16 -1.73 -6.09 0.84 0.67 3.93 6.2 8.14 Dividends SEK Payout Ratio % * Shares Mil 26.0 27.0 32.0 32.0 34.0 34.0 35.0 35.0 35.0 35.0 35.0 Book Value Per Share * SEK 19.91 19.48 7.23 5.82 11.62 9.44 7.84 8.69 12.28 19.35 22.66 Free Cash Flow Per Share * SEK -1.34 -4.05 1.83 -8.33 -22.38 -3.81 2.22 6.95 4.11 8.13 Return on Assets % -13.1 -62.28 -16.71 -24.71 -5.66 -17.66 2.85 2.29 12.04 15.72 19.71 Financial Leverage (Average) 1.52 1.76 2.52 4.78 2.69 3.81 3.28 3.05 2.7 2.13 2.0 Return on Equity % -17.55 -100.6 -34.19 -87.87 -18.36 -54.88 10.06 7.26 34.25 37.06 45.22 Return on Invested Capital % -14.55 -77.76 -21.32 -50.58 -6.67 -21.06 6.48 5.93 20.54 24.44 29.02 Interest Coverage -8.98 -31.43 -6.14 -9.55 -1.52 -7.3 2.53 2.36 6.59 12.69 Current Ratio 1.88 3.01 1.73 1.09 3.49 3.3 2.69 2.36 2.19 2.65 2.69 Quick Ratio 1.83 2.78 1.5 0.3 1.68 1.69 1.55 1.62 1.77 2.32 2.39 Debt/Equity 0.2 0.37 0.59 0.64 1.09 1.86 1.28 0.97 0.67 0.46 0.39